Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Microchip Technology Incorporated's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $41.2B | |
|---|---|---|
| Revenue (ttm) | 5.1B | |
| Net income (ttm) | 367.2M | |
| EPS (ttm) | $0.68 | |
| Shares out | 543M | |
| P/E (trailing) | 117.4x | |
| P/E (forward) | 20.5x | |
| Dividend | $1.82 (2.30%) | |
| Volume | 6,184,831 | |
| Beta | 1.76 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | Trend |
| Revenue | $6.82B | $8.44B | $7.63B | $4.40B | $4.71B | -8.8% |
| Gross profit | $4.45B | $5.70B | $5.00B | $2.47B | $2.72B | -11.6% |
| Operating income | $1.85B | $3.12B | $2.57B | $296.3M | $490.1M | -28.3% |
| Net income | $1.29B | $2.24B | $1.91B | $-500.0K | $230.0M | -35.0% |
| EPS (diluted) | $2.27 | $4.02 | $3.48 | $-0.01 | $0.22 | -44.2% |
| EBITDA | $2.87B | $4.10B | $3.44B | $1.04B | $1.40B | -16.4% |
| R&D | $989.1M | $1.12B | $1.10B | $983.8M | $1.09B | +2.4% |
| SG&A | $718.9M | $797.7M | $734.2M | $617.7M | $674.3M | -1.6% |
Recent company headlines from major financial publishers.
In the bull scenario, industrial automation and automotive demand experience a synchronized cyclical rebound, while data center AI connectivity design wins ramp faster than planned. Book-to-bill sustains comfortably above 1.1x, enabling fab utilization to exceed 85% and driving operating margins toward 38%. Under these conditions, FY2028 revenue accelerates beyond $8.39B and diluted EPS reaches the upper analyst consensus range of $5.44,.
The base scenario reflects the house forecast schedule where net sales recover +35.6% in FY2027 to $6,391.0M and +16.1% in FY2028 to $7,419.9M, tracking analyst consensus estimates,. Operating margins expand from 10.40% in FY2026 to 25.0% in FY2027 and 32.5% in FY2028, yielding diluted EPS of $3.65 and $4.58 respectively,. Capital reinvestment is maintained at 12% of NOPAT based on capex guidance of $100M and long-term tax rate remains at 19.04%.
| Ke ↓ / g → | 2.5% | 2.8% | 3.0% | 3.3% | 3.5% |
|---|---|---|---|---|---|
| 10.8% | $55.3 | $56.1 | $57.0 | $57.9 | $58.9 |
| 11.3% | $52.9 | $53.5 | $54.3 | $55.1 | $55.9 |
| 11.8% | $50.6 | $51.2 | $51.8 | $52.5 | $53.2 |
| 12.3% | $48.6 | $49.1 | $49.6 | $50.2 | $50.9 |
| 12.8% | $46.7 | $47.1 | $47.6 | $48.2 | $48.7 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
